In a small, randomized Phase I/II clinical trial (SAT1), researchers say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.
from Top Health News – ScienceDaily http://ift.tt/2rZ3WEB
from Tumblr http://ift.tt/2r5lij7
No comments:
Post a Comment